Central adaptation to chronic administration of interleukin-1β (IL-1β) in rats

Brain Research Bulletin

Volumn 62, Issue 1, 2003, Pages 71-76

  MohanKumar, Sheba M J ^a   Smith, Courtney L ^a   MohanKumar, P S ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Body weight; Corticosterone; Food intake; Hypothalamus; Interleukin; Median eminence; Neuro immune interactions; Norepinephrine; Paraventricular nucleus

Indexed keywords

INTERLEUKIN 1BETA; NORADRENALIN;

ACUTE DRUG ADMINISTRATION; ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC DRUG ADMINISTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG EFFECT; FOOD INTAKE; HYPOTHALAMUS; MALE; MEDIAN EMINENCE; NEUROENDOCRINOLOGY; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE; THALAMUS MIDLINE NUCLEUS;

EID: 0142226865     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2003.09.001     Document Type: Article

References (33)

1. Avitsur R., Pollak Y., Yirmiya R. Administration of interleukin-1 into the hypothalamic paraventricular nucleus induces febrile and behavioral effects. Neuroimmunomodulation. 4:1997;258-265.
2. Busbridge N.J., Dascombe M.J., Rothwell N.J. Chronic effects of interleukin-1β on fever, oxygen consumption and food intake in the rat. Horm. Metab. Res. 25:1993;222-227.
3. Dinarello C.A. Interleukin-1. Cytokine Growth Factor Rev. 8:1997;253-265.
4. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52:2000;595-638.
5. B.J. Everitt, B. Meister, T. Hokfelt, The organization of monoaminergic neurons in the hypothalamus in relation to neuroendocrine integration, in: C.B. Nemeroff (Ed.), Neuroendocrinology, CRC Press, Boca Raton, 1992, pp. 87-128.
6. Finck B.N., Johnson R.W. Anorexia, weight loss and increased plasma interleukin-6 caused by chronic intracerebroventricular infusion of interleukin-1beta in the rat. Brain Res. 761:1997;333-337.
7. Francis J., MohanKumar S.M., MohanKumar P.S. Correlations of norepinephrine release in the paraventricular nucleus with plasma corticosterone and leptin after systemic lipopolysaccharide; blockade by soluble IL-1 receptor. Brain Res. 867:2000;180-187.
8. Hasko G., Shanley T.P., Egnaczyk G., Nemeth Z.H., Salzman A.L., Vizi E.S., Szabo C. Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism. Br. J. Pharmacol. 125:1998;1297-1303.
9. Hill A.G., Jacobson L., Gonzalez J., Rounds J., Majzoub J.A., Wilmore D.W. Chronic central nervous system exposure to interleukin-1 beta causes catabolism in the rat. Am. J. Physiol. 271:1996;R1142-R1148.
10. Kondo S., Shinomura Y., Kanayama S., Kawabata S., Miyazaki Y., Imamura I., Fukui H., Matsuzawa Y. Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat. Am. J. Physiol. 267:1994;G966-G971.
11. Krueger J.M., Obal F.J., Fang J., Kubota T., Taishi P. The role of cytokines in physiological sleep regulation. Ann. N. Y. Acad. Sci. 933:2001;211-221.
12. Le Feuvre R.A., Aisenthal L., Rothwell N.J. Involvement of corticotrophin releasing factor (CRF) in the thermogenic and anorexic actions of serotonin (5-HT) and related compounds. Brain Res. 555:1991;245-250.
13. Ling P.R., Schwartz J.H., Jeevanandam M., Gauldie J., Bistrian B.R. Metabolic changes in rats during a continuous infusion of recombinant interleukin-1. Am. J. Physiol. 270:1996;E305-E312.
14. MohanKumar P.S., Quadri S.K. Systemic administration of interleukin-1 stimulates norepinephrine release in the paraventricular nucleus. Life Sci. 52:1993;1961-1967.
15. MohanKumar S.M., MohanKumar P.S., Quadri S.K. Specificity of interleukin-1beta-induced changes in monoamine in hypothalamic nuclei: blockade by interleukin-1 receptor antagonist. Brain Res. Bull. 47:1998;29-34.
16. MohanKumar S.M., MohanKumar P.S., Quadri S.K. Effects of bacterial lipopolysaccharide on central monoamines and fever in the rat: involvement of the vagus. Neurosci. Lett. 284:2000;159-162.
17. Mrosovsky N., Molony L.A., Conn C.A., Kluger M.J. Anorexic effects of interleukin-1 in the rat. Am. J. Physiol. 257:1989;R1315-R1321.
18. E.E. Muller, G. Nistico, Brain Messengers and the Pituitary, Academic Press, San Diego, 1988.
19. Parsadaniantz S.M., Gaillet S., Malaval F., Lenoir V., Batsche E., Barbanel G., Gardier A., Terlain B., Jacquot C., Szafarczyk A. Lesions of the afferent catecholaminergic pathways inhibit the temporal activation of the CRH and POMC gene expression and ACTH release induced by human interleukin-1beta in the male rat. Neuroendocrinology. 62:1995;586-595.
20. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, New York.
21. Plata-Salaman C.R. Dexamethasone inhibits food intake suppression induced by low doses of interleukin-1 beta administered intracerebroventricularly. Brain Res. Bull. 27:1991;737-738.
22. Plata-Salaman C.R., Sonti G., Borkoski J.P., Wilson C.D., French-Mullen J.M. Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations. Physiol. Behav. 60:1996;867-875.
23. Rivest S., Rivier C. Interleukin-1 beta inhibits the endogenous expression of the early gene c-fos located within the nucleus of LH-RH neurons and interferes with hypothalamic LH-RH release during proestrus in the rat. Brain Res. 613:1993;132-142.
24. Rothwell N.J. CRF is involved in the pyrogenic and thermogenic effects of interleukin 1 beta in the rat. Am. J. Physiol. 256:1989;E111-E115.
25. Roubenoff R., Freeman L.M., Smith D.E., Abad L.W., Dinarello C.A., Kehayias J.J. Adjuvant arthritis as a model of inflammatory cachexia. Arthritis Rheum. 40:1997;534-539.
26. Saperas E., Yang H., Tache Y. Interleukin-1 beta acts at hypothalamic sites to inhibit gastric acid secretion in rats. Am. J. Physiol. 263:1992;G414-G418.
27. Suto G., Kiraly A., Tache Y. Interleukin 1 beta inhibits gastric emptying in rats: mediation through prostaglandin and corticotropin-releasing factor. Gastroenterology. 106:1994;1568-1575.
28. Tache Y., Monnikes H., Bonaz B., Rivier J. Role of CRF in stress-related alterations of gastric and colonic motor functions. Ann. N. Y. Acad. Sci. 697:1993;233-243.
29. Tilders F.J., Schmidt E.D. Interleukin-1-induced plasticity of hypothalamic CRH neurons and long-term stress hyperresponsiveness. Ann. N. Y. Acad. Sci. 840:1998;65-73.
30. Turnbull A.V., Rivier C. Regulation of the HPA axis by cytokines. Brain Behav. Immun. 9:1995;253-275.
31. Uehara A., Sekiya C., Takasugi Y., Namiki M., Arimura A. Anorexia induced by interleukin 1: involvement of corticotropin-releasing factor. Am. J. Physiol. 257:1989;R613-R617.
32. Van der Meer M.J., Sweep C.G., Pesman G.J., Borm G.F., Hermus A.R. Synergism between IL-1β and TNF-α on the activity of the pituitary-adrenal axis and on food intake of rats. Am. J. Physiol. 268:1995;E551-E557.
33. Weingarten S., Savoldelli D., Langhans W. Enhancement or loss of the hypophagic effect of interleukin-1 upon chronic administration. Physiol. Behav. 52:1992;831-837.